| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 2-Jan-09 | | Total Revenue | 117,508 | 73,378 | 63,754 | 107,441 | | Cost of Revenue | 64,165 | 45,217 | 42,493 | 67,538 | | | Gross Profit | 53,343 | 28,161 | 21,261 | 39,903 | | | Operating Expenses | | Research Development | 19,889 | 19,104 | 18,990 | 22,080 | | Selling General and Administrative | 23,193 | 22,150 | 24,090 | 26,760 | | Non Recurring | 187 | 672 | 2,051 | 6,249 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,074 | (13,765) | (23,870) | (15,186) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 564 | 918 | 902 | 1,811 | | Earnings Before Interest And Taxes | 10,638 | (12,847) | (22,968) | (13,375) | | Interest Expense | 66 | 92 | 593 | 178 | | Income Before Tax | 10,572 | (12,939) | (23,561) | (13,553) | | Income Tax Expense | 1,131 | 1,318 | (3,937) | 5 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,441 | (14,257) | (19,624) | (13,558) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,441 | (14,257) | (19,624) | (13,558) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,441 | ($14,257) | ($19,624) | ($13,558) |
|
0.01% Nasdaq 
0.45%
Income Statement
